On a Tuesday in late May, Carmel Partners closed on a 49 percent stake in five Upper West Side apartment buildings. The seller was MetLife. The price: a $485 million valuation for the portfolio, per sources.

The portfolio is the Columbus Square Collection: 801 Amsterdam Avenue and 775, 795, 805 and 808 Columbus Avenue. UDR, the publicly traded REIT, remains the majority owner. The buildings total 492,000 square feet and 707 units, constructed in 2009.

Carmel is stepping into in-place Fannie Mae debt provided by Wells Fargo. The interest rate: 2.6 percent. The maturity: 2031. That is fixed-rate financing secured in a different rate era, now assumed by a new sponsor.

The portfolio is 50 percent market-rate and 50 percent rent-stabilized. The building at 808 Columbus Avenue benefits from a 421a tax abatement through 2031, with its exemption percentage currently at 60 percent. That tax shield matters in a market where operating margins face pressure from insurance and labor costs.

UDR and MetLife bought the portfolio in 2012 for $630 million from Stellar Management and Chetrit Group. The current $485 million valuation represents a 23 percent decline from the 2012 purchase price. That is not a markdown on replacement cost; it is a reflection of where interest rates and rent regulation have moved.

Newmark’s Adam Spies, Adam Doneger, Marcella Fasulo, Doug Harmon and Michael Collins negotiated the sale. MetLife and Newmark declined to comment. Carmel Partners did not return a request for comment.

The deal structure is instructive. Carmel acquires a minority stake, not control. It steps into debt priced at 2.6 percent, a coupon that no new construction or acquisition financing today can match. The effective cost of capital on this equity is a function of that embedded debt subsidy.

For MetLife, the sale represents a partial exit from a 14-year hold. The insurer likely booked a loss relative to its 2012 basis, but the trade frees capital for deployment into higher-yielding opportunities. For UDR, the partnership brings a new institutional co-owner with deep multifamily operating expertise.

For Carmel Partners, the acquisition is a bet on New York City rent-stabilized multifamily at a time when the state’s rent laws remain restrictive and the city’s housing supply crisis persists. The 2.6 percent debt is the anchor that makes the math work.

The broader implication: institutional capital is rotating into multifamily assets with locked-in low-cost debt. The 2.6 percent coupon is an asset in itself. In a world where SOFR is above 4 percent and agency spreads have widened, assuming a 2.6 percent fixed rate through 2031 is the equivalent of a 200-plus basis point yield subsidy.

This deal also signals that the bid-ask spread in New York multifamily is narrowing. Sellers like MetLife are willing to transact at valuations below prior peaks. Buyers like Carmel are willing to step in when the financing structure provides a margin of safety that current market rates cannot replicate.

The Columbus Square Collection traded at roughly $686 per square foot and $686,000 per unit. That is below peak pricing but above distressed levels. The rent-stabilized component caps upside but provides cash flow stability. The 421a abatement at 808 Columbus adds a tailwind through 2031.

What comes next: expect more minority-stake transactions in stabilized New York multifamily. The combination of low-basis debt, institutional partnerships, and patient equity is the formula for this cycle. Pure control transactions at market-rate financing are harder to underwrite. The minority stake structure allows buyers to participate in the cash flow without taking full mark-to-market risk on the debt.

Carmel Partners just wrote the playbook. Other firms will follow.